BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 36856043)

  • 1. Nomograms for Prediction of High-Volume Lymph Node Metastasis in Papillary Thyroid Carcinoma Patients.
    Feng JW; Ye J; Qi GF; Hong LZ; Hu J; Wang F; Liu SY; Jiang Y
    Otolaryngol Head Neck Surg; 2023 May; 168(5):1054-1066. PubMed ID: 36856043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of prediction models for determining the risk of lateral lymph node metastasis in patients with thyroid papillary carcinoma based on gender stratification.
    Wu WX; Qi GF; Feng JW; Ye J; Hong LZ; Wang F; Liu SY; Jiang Y
    Eur Arch Otorhinolaryngol; 2023 May; 280(5):2511-2523. PubMed ID: 36622416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nomograms based on sonographic and clinicopathological characteristics to predict lateral lymph node metastasis in classic papillary thyroid carcinoma.
    Feng JW; Wu WX; Qi GF; Hong LZ; Hu J; Liu SY; Jiang Y; Ye J
    J Endocrinol Invest; 2022 Nov; 45(11):2043-2057. PubMed ID: 35809195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prediction model incorporating the BRAF
    Liu S; Liu C; Zhao L; Wang K; Li S; Tian Y; Jiao B; Gui Z; Yu T; Zhang L
    Eur J Surg Oncol; 2021 Nov; 47(11):2774-2780. PubMed ID: 34483032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a nomogram for central lymph node metastasis in papillary thyroid cancer based on gender grouping.
    Qi GF; Feng JW; Wu WX; Ye J; Hu J; Wang F; Hong LZ; Liu SY; Jiang Y
    Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):965-975. PubMed ID: 37975909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nomograms for the prediction of lateral lymph node metastasis in papillary thyroid carcinoma: Stratification by size.
    Feng JW; Ye J; Hong LZ; Hu J; Wang F; Liu SY; Jiang Y; Qu Z
    Front Oncol; 2022; 12():944414. PubMed ID: 36248990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk prediction for central lymph node metastasis in isolated isthmic papillary thyroid carcinoma by nomogram: A retrospective study from 2010 to 2021.
    Zhao Y; Shi W; Dong F; Wang X; Lu C; Liu C
    Front Endocrinol (Lausanne); 2022; 13():1098204. PubMed ID: 36733797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomogram for predicting skip metastasis in cN0 papillary thyroid cancer patients at increased risk of lymph node metastasis.
    Li F; Zhou FJ; Zhu TW; Qiu HL; Zhang XT; Ruan BW; Huang DY
    Adv Clin Exp Med; 2023 Jul; 32(7):753-761. PubMed ID: 36603142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction model of cervical lymph node metastasis based on clinicopathological characteristics of papillary thyroid carcinoma: a dual-center retrospective study.
    Liu W; Zhang D; Jiang H; Peng J; Xu F; Shu H; Su Z; Yi T; Lv Y
    Front Endocrinol (Lausanne); 2023; 14():1233929. PubMed ID: 37766691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective study of papillary thyroid carcinoma: Hashimoto's thyroiditis as a protective biomarker for lymph node metastasis.
    Wang Y; Zheng J; Hu X; Chang Q; Qiao Y; Yao X; Zhou X
    Eur J Surg Oncol; 2023 Mar; 49(3):560-567. PubMed ID: 36404253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of nomograms for predicting the risk of central lymph node metastasis of solitary papillary thyroid carcinoma of the isthmus.
    Li Y; Gao X; Guo T; Liu J
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14853-14868. PubMed ID: 37598343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomograms to predict ipsilateral and contralateral central lymph node metastasis in clinically lymph node-negative patients with solitary isthmic classic papillary thyroid carcinoma.
    Feng JW; Qu Z; Ye J; Hong LZ; Liu SY; Wang F; Jiang Y; Hu J
    Surgery; 2021 Dec; 170(6):1670-1679. PubMed ID: 34275617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative prediction of central lymph node metastasis in cN0T1/T2 papillary thyroid carcinoma: A nomogram based on clinical and ultrasound characteristics.
    Li J; Sun P; Huang T; Li L; He S; Ai X; Xiao H; Xue G
    Eur J Surg Oncol; 2022 Jun; 48(6):1272-1279. PubMed ID: 35414404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors associated with preferential lateral lymph node metastasis in papillary thyroid carcinoma.
    Shao L; Wang Z; Dong W; Sun W; Zhang H
    Cancer Med; 2023 Nov; 12(22):20670-20676. PubMed ID: 37905599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and validation of nomograms to reduce completion thyroidectomy by predicting lymph node metastasis in low-risk papillary thyroid carcinoma.
    Wang R; Tang Z; Wu Z; Xiao Y; Li J; Zhu J; Zhang X; Ming J
    Eur J Surg Oncol; 2023 Aug; 49(8):1395-1404. PubMed ID: 37061404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
    Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z
    BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating US-guided FNAB, BRAF
    Ma N; Tian HY; Yu ZY; Zhu X; Zhao DW
    Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5565-5574. PubMed ID: 37540271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasonic Feature Prediction of Large-Number Central Lymph Node Metastasis in Clinically Node-Negative Solitary Papillary Thyroid Carcinoma.
    Xiao W; Hu X; Zhang C; Qin X
    Endocr Res; 2023 Oct; 48(4):112-119. PubMed ID: 37606889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomograms based on preoperative multimodal ultrasound of papillary thyroid carcinoma for predicting central lymph node metastasis.
    Dai Q; Liu D; Tao Y; Ding C; Li S; Zhao C; Wang Z; Tao Y; Tian J; Leng X
    Eur Radiol; 2022 Jul; 32(7):4596-4608. PubMed ID: 35226156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Nomogram Based on Clinical and Ultrasound Characteristics to Predict Central Lymph Node Metastasis of Papillary Thyroid Carcinoma.
    Feng JW; Hong LZ; Wang F; Wu WX; Hu J; Liu SY; Jiang Y; Ye J
    Front Endocrinol (Lausanne); 2021; 12():666315. PubMed ID: 33995284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.